| |
| |
|
| Insider
Information: |
Hakim Nasrat A |
| Relationship: |
CEO, President, Direct... |
| City: |
Northvale |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
216,649,250 |
|
|
Indirect Shares
|
4,923,147 |
|
|
| Direct
Value |
$35,985,440 |
|
|
|
Indirect Value
|
$817,735 |
|
|
| Total
Shares |
221,572,397 |
|
|
| Total
Value |
$36,803,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Elite Pharmaceuticals Inc |
ELTP |
CEO, President, Direct... |
2024-03-29 |
216,649,250 |
2024-03-29 |
4,923,147 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELTP |
Elite Pharmaceuticals Inc |
CEO, President |
• • • |
2024-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
49,534,368 |
216,649,250 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
CEO, President |
• • • |
2023-12-29 |
4 |
A |
$0.07 |
$153,397 |
I/I |
2,223,147 |
2,223,147 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
CEO & President |
• • • |
2020-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
158,017,321 |
167,114,882 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
CEO & President |
• • • |
2017-04-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(158,017,321) |
9,097,561 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
CEO & President |
• • • |
2017-02-23 |
4 |
A |
$0.23 |
$499,932 |
D/D |
2,216,992 |
24,143,785 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
CEO & President |
• • • |
2016-08-17 |
4 |
OE |
$0.00 |
$0 |
I/I |
142,857,143 |
142,971,097 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Chairman, CEO, President |
• • • |
2016-02-16 |
4 |
A |
$0.25 |
$699,869 |
D/D |
2,854,279 |
22,040,747 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
President & CEO |
• • • |
2015-06-02 |
4 |
OE |
$0.06 |
$171,363 |
I/I |
2,741,801 |
5,311,819 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
President & CEO |
• • • |
2015-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
2,570,018 |
2,570,018 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
President & CEO |
• • • |
2015-03-05 |
4 |
A |
$0.34 |
$699,921 |
D/D |
2,046,554 |
13,760,695 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
CEO & President |
• • – |
2014-09-26 |
4 |
B |
$0.31 |
$82,385 |
I/I |
265,500 |
2,700,000 |
2.66 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
CEO & President |
• • – |
2014-09-25 |
4 |
B |
$0.31 |
$133,956 |
I/I |
434,500 |
2,434,500 |
2.66 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
President & CEO |
• • • |
2014-02-25 |
4 |
A |
$0.11 |
$291,487 |
D/D |
2,616,580 |
11,714,141 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
President & CEO |
• • • |
2014-02-07 |
4 |
OE |
$100,000.00 |
$10,000,000 |
I/I |
100 |
100 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
President & CEOOfficer |
• • – |
2013-08-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,000,000 |
|
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
President & CEOOfficer |
• • – |
2013-08-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,097,561 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
